Phio Pharmaceuticals Corp.
PHIO | NASDAQ
$1.01
-$0.02 (-1.94%)
At close: Sep 21, 2026, 4:00 PM ET
$1.06
+$0.05 (+4.95%)
Pre-market:
Sep 22, 2026, 5:37 AM ET
Fiscal Year Period Ending | FY 2025 Dec 30, 2025 | FY 2024 Dec 30, 2024 | FY 2023 Dec 30, 2023 | FY 2022 Dec 30, 2022 | FY 2021 Dec 30, 2021 | FY 2020 Dec 30, 2020 |
|---|---|---|---|---|---|---|
PE Ratio | -0.72 | -1.98 | -0.15 | -0.45 | -0.97 | -1.40 |
PEG Ratio | -0.01 | 0.02 | 0 | 0.02 | 0.02 | 0.02 |
PS Ratio | n/a | n/a | n/a | n/a | n/a | n/a |
PB Ratio | 0.31 | 0.30 | 0.20 | 0.47 | 0.58 | 0.95 |
P/FCF Ratio | -0.79 | -0.20 | -0.15 | -0.41 | -1.08 | -1.40 |
P/OCF Ratio | -0.79 | -0.20 | -0.15 | -0.42 | -1.08 | -1.40 |
OCF/S Ratio | n/a | n/a | n/a | n/a | n/a | n/a |
Debt / Equity Ratio | n/a | n/a | 0 | 0.02 | 0.01 | 0.05 |
Quick Ratio | 49.37 | 5.65 | 5.71 | 6.42 | 8.06 | 6.91 |
Current Ratio | 49.37 | 5.65 | 5.71 | 6.42 | 8.06 | 6.91 |
Asset Turnover | n/a | n/a | n/a | n/a | n/a | n/a |
Interest Coverage | n/a | n/a | n/a | n/a | n/a | n/a |
Return on Equity | -43.17% | -151.39% | -140.05% | -105.90% | -60.58% | -67.56% |
Return on Assets | -40.48% | -124.61% | -115.61% | -89.59% | -52.79% | -55.87% |
Return on Invested Capital | -43.80% | -156.40% | -139.39% | -104.11% | -60.79% | -64.38% |
Dividend Yield | n/a | n/a | n/a | n/a | n/a | n/a |
Payout Ratio | n/a | n/a | n/a | n/a | n/a | n/a |
FCF Payout Ratio | n/a | n/a | n/a | n/a | n/a | n/a |
Gross Profit Margin | n/a | n/a | n/a | n/a | n/a | n/a |
Net Profit Margin | n/a | n/a | n/a | n/a | n/a | n/a |
Pretax Profit Margin | n/a | n/a | n/a | n/a | n/a | n/a |
Operating Profit Margin | n/a | n/a | n/a | n/a | n/a | n/a |
FCF Margin | n/a | n/a | n/a | n/a | n/a | n/a |
EBITDA Margin | n/a | n/a | n/a | n/a | n/a | n/a |
Add to Watchlist
Select watchlists to add or remove PHIO